ASGN downgraded to Market Perform from Outperform at BMO Capital

BMO Capital downgraded ASGN (ASGN) to Market Perform from Outperform with a $33 price target The firm is reducing estimates following “disappointing” Q1 results and “weak” Q2 guidance. Though there could be some recovery over the year, it is “difficult to recommend this name as these results fuel the AI bear-case narrative” and the increased debt levels following the recent Quinnox acquisition “may deter deep value investors from establishing a position,” the analyst argues.